Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway

10.3390/cancers13215479

Saved in:

Bibliographic Details
Main Authors:	Arora, Loukik, Mohan, Chakrabhavi Dhananjaya, Yang, Min Hee, Rangappa, Shobith, Deivasigamani, Amudha, Kumar, Alan Prem, Kunnumakkara, Ajaikumar B., Garg, Manoj, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Alahmadi, Tahani Awad, Rangappa, Kanchugarakoppal S., Hui, Kam Man, Sethi, Gautam, Ahn, Kwang Seok
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	MDPI 2022
Subjects:	Orthotopic SHP2 STAT3 signaling inhibitor Tris DBA Xenograft
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/232792
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-232792
record_format	dspace
spelling	sg-nus-scholar.10635-2327922024-11-13T12:55:34Z Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway Arora, Loukik Mohan, Chakrabhavi Dhananjaya Yang, Min Hee Rangappa, Shobith Deivasigamani, Amudha Kumar, Alan Prem Kunnumakkara, Ajaikumar B. Garg, Manoj Chinnathambi, Arunachalam Alharbi, Sulaiman Ali Alahmadi, Tahani Awad Rangappa, Kanchugarakoppal S. Hui, Kam Man Sethi, Gautam Ahn, Kwang Seok PHARMACOLOGY INSTITUTE OF MOLECULAR & CELL BIOLOGY Orthotopic SHP2 STAT3 signaling inhibitor Tris DBA Xenograft 10.3390/cancers13215479 Cancers 13 21 5479 2022-10-13T01:11:23Z 2022-10-13T01:11:23Z 2021-10-31 Article Arora, Loukik, Mohan, Chakrabhavi Dhananjaya, Yang, Min Hee, Rangappa, Shobith, Deivasigamani, Amudha, Kumar, Alan Prem, Kunnumakkara, Ajaikumar B., Garg, Manoj, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Alahmadi, Tahani Awad, Rangappa, Kanchugarakoppal S., Hui, Kam Man, Sethi, Gautam, Ahn, Kwang Seok (2021-10-31). Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway. Cancers 13 (21) : 5479. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers13215479 2072-6694 https://scholarbank.nus.edu.sg/handle/10635/232792 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ MDPI Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Orthotopic SHP2 STAT3 signaling inhibitor Tris DBA Xenograft
spellingShingle	Orthotopic SHP2 STAT3 signaling inhibitor Tris DBA Xenograft Arora, Loukik Mohan, Chakrabhavi Dhananjaya Yang, Min Hee Rangappa, Shobith Deivasigamani, Amudha Kumar, Alan Prem Kunnumakkara, Ajaikumar B. Garg, Manoj Chinnathambi, Arunachalam Alharbi, Sulaiman Ali Alahmadi, Tahani Awad Rangappa, Kanchugarakoppal S. Hui, Kam Man Sethi, Gautam Ahn, Kwang Seok Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
description	10.3390/cancers13215479
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Arora, Loukik Mohan, Chakrabhavi Dhananjaya Yang, Min Hee Rangappa, Shobith Deivasigamani, Amudha Kumar, Alan Prem Kunnumakkara, Ajaikumar B. Garg, Manoj Chinnathambi, Arunachalam Alharbi, Sulaiman Ali Alahmadi, Tahani Awad Rangappa, Kanchugarakoppal S. Hui, Kam Man Sethi, Gautam Ahn, Kwang Seok
format	Article
author	Arora, Loukik Mohan, Chakrabhavi Dhananjaya Yang, Min Hee Rangappa, Shobith Deivasigamani, Amudha Kumar, Alan Prem Kunnumakkara, Ajaikumar B. Garg, Manoj Chinnathambi, Arunachalam Alharbi, Sulaiman Ali Alahmadi, Tahani Awad Rangappa, Kanchugarakoppal S. Hui, Kam Man Sethi, Gautam Ahn, Kwang Seok
author_sort	Arora, Loukik
title	Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
title_short	Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
title_full	Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
title_fullStr	Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
title_full_unstemmed	Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
title_sort	tris(dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway
publisher	MDPI
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/232792
_version_	1821200295115358208

Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway

Similar Items